Skip to content
lifestyle.faithfamilyamerica.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lexaria Bioscience Corp.
Lexaria’s Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
June 25, 2026
Lexaria’s Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
June 23, 2026
GLP-1 ‘Arms Race’ Intensifies as the Addressable Markets Continue to Expand
June 17, 2026
Lexaria Bioscience Releases Second Episode of Investor Video Series
May 7, 2026
Lexaria Updates Progress on Human Study #7
May 5, 2026
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications
May 1, 2026
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
April 29, 2026
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
April 23, 2026
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales
April 21, 2026
Lexaria’s New Animal Study Aims to Expand Valuable Intellectual Property
April 15, 2026
1
2
Next Page
→